Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Ondansetron
Medication labelOndansetron orally disintegrating tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer…
Why this: Advisory · dailymed-prescription
Ondansetron orally disintegrating tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron orally disintegrating tablets also indicated for the prevention of postoperative nausea and/or vomiting.
- generic_name
- ondansetron
- product_names
- Ondansetron
- ndc
- 71335-0650, 65862-390, 71335-0650-1, 71335-0650-2, 71335-0650-3, 71335-0650-4, 71335-0650-5, 71335-0650-6, 71335-0650-7, 71335-0650-8, 71335-0650-9, 71335-0650-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en